Patents by Inventor Philippe Labrie

Philippe Labrie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8557804
    Abstract: Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: October 15, 2013
    Assignee: Universite Laval
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene C. Gaudreault, Philippe Labrie
  • Patent number: 8551983
    Abstract: Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: October 8, 2013
    Assignee: Universite Laval
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene C. Gaudreault, Philippe Labrie
  • Publication number: 20110301152
    Abstract: Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
    Type: Application
    Filed: July 8, 2011
    Publication date: December 8, 2011
    Applicant: UNIVERSITE LAVAL
    Inventors: Yvon CORMIER, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene C. Gaudreault, Philippe Labrie
  • Patent number: 8039459
    Abstract: Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: October 18, 2011
    Assignee: Universite Laval
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renée Blanchet, René C. Gaudreault, Philippe Labrie
  • Publication number: 20080221085
    Abstract: Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
    Type: Application
    Filed: July 15, 2005
    Publication date: September 11, 2008
    Applicant: Universite Laval
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene C. Gaudreault, Philippe Labrie
  • Publication number: 20050130990
    Abstract: This invention relates to the use of nicotine receptor agonists or analogues or derivatives thereof for treating inflammatory pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.
    Type: Application
    Filed: July 15, 2004
    Publication date: June 16, 2005
    Applicant: UNIVERSITE LAVAL
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene Gaudreault, Philippe Labrie